Overview

Update
IPO / Stock
Went Public on May 10, 2006 / NASDAQ:TSPT
Total Equity Funding
$40M in 1 Round from 8 Investors
Headquarters:
Richmond, CA
Description:
Transcept Pharmaceuticals focuses on the development of proprietary products that address therapeutic needs in the field of neuroscience.
Founders:
Categories:
Pharmaceutical, Therapeutics, Biotechnology, Neuroscience
Website:
http://www.transoral.com
Social:

Company Details

Update

Transcept Pharmaceuticals, Inc. uses its proprietary delivery system to enhance the penetration of drugs, significantly speeding their onset of action. Transcept is developing rapid-acting versions of several major market pharmaceuticals. Hamilton co-invested in the company's first institutional round of funding alongside Montreaux Equity Partners, Peninsula Equity Partners and Vivo Ventures. Investors in subsequent financing rounds include these firms, and New Leaf Venture Partners, Interwest Partners and New Enterprise Associates.

Funding Rounds (1) - $40M

Update
DateAmount / RoundValuationLead InvestorInvestors
Mar, 2007$40M / Series D8

Board Members and Advisors (1)

Update

Offices/Locations (1)

Update
  • Headquarters

    1003 W. Cutting Blvd

    Suite 110

    Richmond, CA 94804

    USA

Past Team (7)

Update

Images (1)

Update

Add Acquisitions

Add Current Team

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos